Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENACAPAVIR vs LETERMOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENACAPAVIR vs LETERMOVIR: Safety Overview

Metric LENACAPAVIR LETERMOVIR
Total FAERS Reports 502 1,416
Deaths Reported 32 252
Death Rate 6.4% 17.8%
Hospitalizations 42 398
Average Patient Age 50.0 yrs 46.6 yrs
% Female Patients 24.7% 42.7%
FDA Approval Date Dec 22, 2022 Aug 30, 2024
Manufacturer Gilead Sciences, Inc. Merck Sharp & Dohme LLC
Route ORAL ORAL
Marketing Status Prescription Prescription